Term ends Mar 25, 2042 · Low confidence
20-year base term ends Mar 24, 2043
Held by Ventus Therapeutics U.S., Inc.
Filed Jul 3, 2024 as application 18/763,277 · Granted May 27, 2025
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
2023
2043
Clock starts
Mar 24, 2023
Mar 24, 2023
Term ends
Mar 25, 2042
Mar 25, 2042
Granted
May 27, 2025
May 27, 2025
base term
after the term ends
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,618,751, US 12,195,460.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 24, 2023, when the earliest non-provisional application in its chain was filed (this one was filed Jul 3, 2024); a parent in its chain could not be resolved (the next row) | Mar 24, 2043 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,618,751, US 12,195,460) | capped to Mar 25, 2042 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: PCTUS2023064967, PCTUS2023064967 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Mar 25, 2042 | Low confidence |
This family
| US 11,618,751 | In force Mar 2042 | Mar 2042 |
| US 12,168,657 | In force Mar 2042 | Mar 2042 |
| Application PCT/US2023/064967 | PCT application no patent term | no patent term |
| US 12,331,048 | In force Mar 2043 | Mar 2043 |
| US 12,195,460 | In force Mar 2042 | Mar 2042 |
| US 12,312,351 | this patent Mar 2042 | Mar 2042 |
| US 12,398,136 | In force Mar 2043 | Mar 2043 |
| Application 18/799,636 | Pending not computed | not computed |
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 1, 2024 Reel 69102, frame 641 | Dorich, Stéphane; Ciblat, Stéphane | Ventus Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 1, 2024 Reel 69102, frame 699 | Ventus Therapeutics, Inc. | Ventus Therapeutics U.S., Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2042
Term ends Mar 25, 2042. Maintenance fees still fall due before then
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,618,751, US 12,195,460.
Citations
6
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.